IMUNODETECÇÃO DA PROTEÍNA Ep-CAM EM PACIENTES COM CARCINOMAS MAMÁRIOS

by Paganini, Junelle
Published 2016

Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE

by Tomaž Žagar, Miha Pavšič, Aljaž Gaber
Published 2021-05-01

Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1

by Sergey M. Deyev, Tianqi Xu, Yongsheng Liu, Alexey Schulga, Elena Konovalova, Javad Garousi, Sara S. Rinne, Maria Larkina, Haozhong Ding, Torbjörn Gräslund, Anna Orlova, Vladimir Tolmachev, Anzhelika Vorobyeva
Published 2021-07-01

EpCAM (CD326) Regulates Intestinal Epithelial Integrity and Stem Cells via Rho-Associated Kinase

by Takeshi Ouchi, Sohshi Morimura, Lukas E. Dow, Hiroyuki Miyoshi, Mark C. Udey
Published 2021-01-01

Is Ep-CAM Expression a Diagnostic and Prognostic Biomarker for Colorectal Cancer? A Systematic Meta-Analysis

by Susu Han, Shaoqi Zong, Qi Shi, Hongjia Li, Shanshan Liu, Wei Yang, Wen Li, Fenggang Hou
Published 2017-06-01

Anti-Epcam Aptamer (Syl3c)-Functionalized Liposome for Targeted Delivery Of Doxorubicin: In Vitro And In Vivo Antitumor Studies in Mice Bearing C26 Colon Carcinoma

by Mohammad Mashreghi, Parvin Zamani, Seyedeh Alia Moosavian, Mahmoud Reza Jaafari
Published 2020-05-01

Simulation and Stability Assessment of Anti-EpCAM Immunotoxin for Cancer Therapy

by Seyed-Ali Hosseinian, Aliakbar Haddad-Mashadrizeh, Samaneh Dolatabadi
Published 2018-08-01

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs

by Joanna Macdonald, Justin Henri, Kislay Roy, Emma Hays, Michelle Bauer, Rakesh Naduvile Veedu, Normand Pouliot, Sarah Shigdar
Published 2018-01-01

Optical Aptamer Probes of Fluorescent Imaging to Rapid Monitoring of Circulating Tumor Cell

by Ji Yeon Hwang, Sang Tae Kim, Ho-Seong Han, Kyunggon Kim, Jin Soo Han
Published 2016-11-01

Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas

by Henrik Schinke, Theresa Heider, Timm Herkommer, Florian Simon, Alexandra Blancke Soares, Gisela Kranz, Daniel Samaga, Laura Dajka, Annette Feuchtinger, Axel Walch, Laura Valeanu, Christoph Walz, Thomas Kirchner, Martin Canis, Philipp Baumeister, Claus Belka, Cornelius Maihöfer, Sebastian Marschner, Ulrike Pflugradt, Ute Ganswindt, Julia Hess, Horst Zitzelsberger, Olivier Gires
Published 2021-04-01

Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma

by Kazuto Takahashi, Kazuya Ofuji, Katsushi Hiramatsu, Takuto Nosaka, Tatsushi Naito, Hidetaka Matsuda, Katsuya Endo, Masayuki Higuchi, Masahiro Ohtani, Tomoyuki Nemoto, Yasunari Nakamoto
Published 2021-04-01

Absence of EpCAM in cervical cancer cells is involved in sluginduced epithelial‐mesenchymal transition

by Xian Liu, Qian Feng, Yanru Zhang, PengSheng Zheng, Nan Cui
Published 2021-03-01

Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1

by Anzhelika Vorobyeva, Ekaterina Bezverkhniaia, Elena Konovalova, Alexey Schulga, Javad Garousi, Olga Vorontsova, Ayman Abouzayed, Anna Orlova, Sergey Deyev, Vladimir Tolmachev
Published 2020-10-01

Dual Targeting of Cancer Cells with DARPin-Based Toxins for Overcoming Tumor Escape

by Elena Shramova, Galina Proshkina, Victoria Shipunova, Anastasia Ryabova, Roman Kamyshinsky, Andrey Konevega, Aleksey Schulga, Elena Konovalova, Georgij Telegin, Sergey Deyev
Published 2020-10-01

A meta-analysis and The Cancer Genome Atlas data of prostate cancer risk and prognosis using epithelial cell adhesion molecule (EpCAM) expression

by Yu Hu, Qiong Wu, Jialin Gao, Yongrui Zhang, Yuantao Wang
Published 2019-07-01

Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1

by Anzhelika Vorobyeva, Elena Konovalova, Tianqi Xu, Alexey Schulga, Mohamed Altai, Javad Garousi, Sara S. Rinne, Anna Orlova, Vladimir Tolmachev, Sergey Deyev
Published 2020-05-01

Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma

by Jong Jin Sung, Sang Jae Noh, Jun Sang Bae, Ho Sung Park, Kyu Yun Jang, Myoung Ja Chung, Woo Sung Moon
Published 2016-01-01

EpCAM- and/or NCAM-Expressing Hepatocellular Carcinoma in Which Behavior of Hepatic Progenitor Cell Marker-Positive Cells Are Followed

by Atsunori Tsuchiya, Takeshi Suda, Chiyumi Oda, Atsushi Kimura, Kazunori Hosaka, Naruhiro Kimura, Kentaro Tominaga, Kazunao Hayashi, Masaaki Takamura, Shuji Terai
Published 2019-03-01

PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy

by Maxim Rybalov, Hildo J. K. Ananias, Hilde D. Hoving, Henk G. van der Poel, Stefano Rosati, Igle J. de Jong
Published 2014-04-01

EpCAM as a novel therapeutic target for hepatocellular carcinoma

by Vasanthakumar S, Sasikala P, Padma M, Balachandar V, Venkatesh B, Ganesan S
Published 2017-07-01